{"id":"https://genegraph.clinicalgenome.org/r/29c7d377-4f2f-48f0-9444-5f86f6d6107cv1.0","type":"EvidenceStrengthAssertion","dc:description":"*TINF2* was first reported in relation to dyskeratosis congenita, autosomal dominant 3 (MONDO: 0013522) in 2008 (Savage et al., 2008 PMID: 18252230). It is caused by mutations in the *TINF2* gene, which encodes a component of shelterin, a six-protein complex that coats the telomere and is essential for suppressing the DNA damage response at telomeres (Kirwan et al., 2009; PMID:19419704). This disorder is related to telomere biology disorders (DC/TBD) which are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic Dyskeratosis congenita (DC) as well as those with a clinical picture that is dominated by dysfunction of a single organ, such as pulmonary fibrosis. Two forms of DC/TBD with more severe manifestations have been identified, Hoyeraal Hreidarsson syndrome, and Revesz syndrome, which were previously thought to be distinct disorders, but are now recognized to be part of the phenotypic spectrum of DC (Savage SA et al., 2023. Dyskeratosis Congenita and Related Telomere Biology Disorders. GeneReviews). While pulmonary fibrosis is part of the phenotypic spectrum of DC, cases of isolated fibrotic interstitial lung disease have been  observed without other characteristic features of DC. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism or inheritance pattern between these conditions suggesting that these may constitute a disease spectrum associated with variants in *TINF2*. Therefore, the four conditions– dyskeratosis congenita, autosomal dominant 3 (OMIM:613990), Revesz syndrome (OMIM:268130), Hoyeraal-Hreidarsson syndrome (ORPHA:3322), and pulmonary fibrosis (OMIM:178500),  have been lumped into one disease entity–  *TINF2*-related short telomere syndrome. \n\nEight variants that have been reported in 12 probands in 7 publications (Tsangaris E, et al., 2008, PMID:18979121; Sasa GS, et al., 2012, PMID:21477109; Savage SA, et al., 2008, PMID:18252230; v Walne AJ, et al., 2008, PMID:18669893; Touzot F, et al., 2012, PMID:22078571; Geng J, et al., 2022, PMID:36073719; Vulliamy T, et al., 2012, PMID:21199492), are included in this curation.  This gene-disease relationship is also supported by protein interactions,  functional alteration studies, a cell-culture model, a mouse model  (Liu D, et al., 2004, PMID:15181449; Touzot F, et al., 2012, PMID:22078571; Yang D, et al., 2011, PMID:21536674; Choo S et al., 2022, PMID:35421215; Frescas D et al., 2014, PMID:24449270; Frank AK et al., 2015, PMID:26230315 ). More evidence is available in the literature, but the maximum score for genetic evidence has been reached. In summary, there is definitive evidence to support the relationship between *TINF2* and *TINF2*-related short telomere syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Interstitial Lung Disease GCEP on the meeting date November 19, 2024 (SOP Version 11). \n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/29c7d377-4f2f-48f0-9444-5f86f6d6107c","GCISnapshot":"https://genegraph.clinicalgenome.org/r/b32866f2-6fa1-4a63-9624-3588d0811ea7","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/b32866f2-6fa1-4a63-9624-3588d0811ea7_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10138","date":"2025-02-20T17:43:56.843Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/b32866f2-6fa1-4a63-9624-3588d0811ea7_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10138","date":"2025-02-20T17:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b32866f2-6fa1-4a63-9624-3588d0811ea7_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dcc85b5b-7a8b-4411-b72b-b892cd489672","type":"EvidenceLine","dc:description":"This variant is absent from gnomAD. ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dcc85b5b-7a8b-4411-b72b-b892cd489672_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21199492","allele":{"id":"https://genegraph.clinicalgenome.org/r/458fd2ee-8d65-4840-9ed6-188158271151","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001099274.3(TINF2):c.826del (p.Arg276GlyfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA278909"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e3c705b4-0d31-4ebc-a64f-f65b3ca48345","type":"EvidenceLine","dc:description":"Variant is absent from gnomAD.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e3c705b4-0d31-4ebc-a64f-f65b3ca48345_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18252230","allele":{"id":"https://genegraph.clinicalgenome.org/r/0ffb7074-3231-4929-b25c-39d2646e5ffe","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001099274.3(TINF2):c.838A>G (p.Lys280Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA117650"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/5b7ade19-ca5d-4a2f-bef8-27ce234506e8","type":"EvidenceLine","dc:description":"Variant is absent from gnomAD.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b7ade19-ca5d-4a2f-bef8-27ce234506e8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21477109","allele":{"id":"https://genegraph.clinicalgenome.org/r/dcb9dae7-f299-4cc4-8e87-cb662bfcc0b0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001099274.3(TINF2):c.811C>T (p.Gln271Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA129793"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/1aae7160-b31d-4908-95f6-a5aab707ec33","type":"EvidenceLine","dc:description":"Variant is absent from gnomAD","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1aae7160-b31d-4908-95f6-a5aab707ec33_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18979121","allele":{"id":"https://genegraph.clinicalgenome.org/r/68e1c46e-f566-432a-8733-31e710a09db7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001099274.3(TINF2):c.845G>A (p.Arg282His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA117651"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/b32866f2-6fa1-4a63-9624-3588d0811ea7_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/68507d53-84dd-4b76-a542-cfe522fe796f_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21477109","rdfs:label":"Family 2","family":{"id":"https://genegraph.clinicalgenome.org/r/68507d53-84dd-4b76-a542-cfe522fe796f","type":"Family","rdfs:label":"Family 2","ethnicity":{"id":"cg:HispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/cc7cf315-822a-4e0c-a2aa-2641eba6f623","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21477109","rdfs:label":"Sasa Proband 2","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":21,"allele":{"id":"https://genegraph.clinicalgenome.org/r/99cf5852-68d3-40c3-a5e7-9e02d6be6bdf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001099274.3(TINF2):c.839del (p.Lys280ArgfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA913187374"}},"ethnicity":{"id":"cg:HispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Due to the severity of his bone marrow failure, the patient underwent matched umbilical cord blood transplantation following reduced intensity conditioning (RIC). He experienced multiple complications resulting in his death on day +92 after transplant.","phenotypes":["obo:HP_0000750","obo:HP_0000488","obo:HP_0002194","obo:HP_0001321","obo:HP_0002745","obo:HP_0001875","obo:HP_0001522","obo:HP_0001972","obo:HP_0008404","obo:HP_0002136","obo:HP_0002370"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6ac99ef6-a99d-40e5-b2ec-7a3b049621af_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21477109","allele":{"id":"https://genegraph.clinicalgenome.org/r/99cf5852-68d3-40c3-a5e7-9e02d6be6bdf"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/cc7cf315-822a-4e0c-a2aa-2641eba6f623"}},{"id":"https://genegraph.clinicalgenome.org/r/1a014890-c412-4fd3-8cf2-abfaa7c39ad7_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18252230","rdfs:label":"Family A","family":{"id":"https://genegraph.clinicalgenome.org/r/1a014890-c412-4fd3-8cf2-abfaa7c39ad7","type":"Family","rdfs:label":"Family A","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/7c3c6251-89fd-4a6f-b5a1-740b5e07affe","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18252230","rdfs:label":"Patient III-07","ageType":"AgeAtReport","ageUnit":"Years","ageValue":10,"allele":{"id":"https://genegraph.clinicalgenome.org/r/0ffb7074-3231-4929-b25c-39d2646e5ffe"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Linkage analysis","phenotypes":["obo:HP_0001915","obo:HP_0008404","obo:HP_0000953","obo:HP_0002745"],"previousTesting":true,"previousTestingDescription":"A linkage scan was performed on a family with autosomal-dominant DC and no mutations in DKCI, TERC, or TERT.","secondTestingMethod":"PCR","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/e3c705b4-0d31-4ebc-a64f-f65b3ca48345_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":6,"proband":{"id":"https://genegraph.clinicalgenome.org/r/7c3c6251-89fd-4a6f-b5a1-740b5e07affe"},"publishedLodScore":2.62,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/81e9126f-8ab8-46a0-9ef8-db7714f843d8_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18252230","rdfs:label":"Family C","family":{"id":"https://genegraph.clinicalgenome.org/r/81e9126f-8ab8-46a0-9ef8-db7714f843d8","type":"Family","rdfs:label":"Family C","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/fbd0e231-4aa0-4257-91ee-215c52c52c43","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18252230","rdfs:label":"Savage Proband C","ageType":"AgeAtReport","ageUnit":"Years","ageValue":1,"allele":{"id":"https://genegraph.clinicalgenome.org/r/68e1c46e-f566-432a-8733-31e710a09db7"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0031413","obo:HP_0008404","obo:HP_0001321","obo:HP_0001915","obo:HP_0001263","obo:HP_0000953","obo:HP_0007898","obo:HP_0001522"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/5ec98da1-162e-4c2e-bd14-977116989334_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18252230","allele":{"id":"https://genegraph.clinicalgenome.org/r/68e1c46e-f566-432a-8733-31e710a09db7"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/fbd0e231-4aa0-4257-91ee-215c52c52c43"}},{"id":"https://genegraph.clinicalgenome.org/r/fd006f3f-e3b2-4da4-8280-8a9d883a5dde_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21477109","rdfs:label":"Family 3","family":{"id":"https://genegraph.clinicalgenome.org/r/fd006f3f-e3b2-4da4-8280-8a9d883a5dde","type":"Family","rdfs:label":"Family 3","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/d88b7c06-11d3-4de5-8208-9ed7f12e70fc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21477109","rdfs:label":"Sasa Proband 3","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":21,"allele":{"id":"https://genegraph.clinicalgenome.org/r/dcb9dae7-f299-4cc4-8e87-cb662bfcc0b0"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":" Vanishing nails; at the age 10 years, she had progressive interstitial lung disease with fibrosis. She eventually developed hepatopulmonary syndrome and died at the age of 12 years from multi-organ failure.","phenotypes":["obo:HP_0002239","obo:HP_0011421","obo:HP_0001972","obo:HP_0009926","obo:HP_0002745","obo:HP_0008404","obo:HP_0001873","obo:HP_0002043","obo:HP_0000953","obo:HP_0001882","obo:HP_0001875","obo:HP_0000938"],"previousTesting":true,"previousTestingDescription":"DKC1 and TERC sequencing of a buccal sample were normal.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/5b7ade19-ca5d-4a2f-bef8-27ce234506e8_variant_evidence_item"}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/d88b7c06-11d3-4de5-8208-9ed7f12e70fc"}},{"id":"https://genegraph.clinicalgenome.org/r/1e5980eb-e7c9-4714-991a-97922d98e9e2_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18979121","rdfs:label":"Family 1 ","family":{"id":"https://genegraph.clinicalgenome.org/r/1e5980eb-e7c9-4714-991a-97922d98e9e2","type":"Family","rdfs:label":"Family 1 ","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/2d8dd793-dada-407a-9258-349b4059179c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18979121","rdfs:label":"Tsangaris Proband 1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":23,"allele":{"id":"https://genegraph.clinicalgenome.org/r/68e1c46e-f566-432a-8733-31e710a09db7"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Poor balance starting at 18-months-old, slow weigh gain and on a CT scan imaging a small hemorrhages in the cerebellum and corpus callosum.","phenotypes":["obo:HP_0000750","obo:HP_0001251","obo:HP_0031413","obo:HP_0002745"],"previousTesting":true,"previousTestingDescription":"Gene mutation analysis performed of all exons and flanking sequences of TERT, NOP10 and DKC1, and of exon 1 of the TERC gene and sequencing of exon 2 of the SBDS gene and exons 1–12 of the MPL gene. Due to the family history, SOX9 was also sequenced and was normal.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/1aae7160-b31d-4908-95f6-a5aab707ec33_variant_evidence_item"}}},"phenotypePositiveAllelePositive":1,"phenotypes":"obo:HP_0005268","proband":{"id":"https://genegraph.clinicalgenome.org/r/2d8dd793-dada-407a-9258-349b4059179c"}},{"id":"https://genegraph.clinicalgenome.org/r/074dab04-5e5e-4412-a6a1-9026cc5b34a7_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21477109","rdfs:label":"Family 1","family":{"id":"https://genegraph.clinicalgenome.org/r/074dab04-5e5e-4412-a6a1-9026cc5b34a7","type":"Family","rdfs:label":"Family 1","ethnicity":{"id":"cg:HispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/ba806164-f496-4d51-8f90-c3f402135835","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21477109","rdfs:label":"Sasa Proband 1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/19411159-647d-469d-9c07-358d7e334c1d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001099274.3(TINF2):c.805C>T (p.Gln269Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA129791"}},"ethnicity":{"id":"cg:HispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0000953","obo:HP_0001876","obo:HP_0008404","obo:HP_0002745"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/2843ee25-73d2-47e4-861b-cc4a00efd0ce_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21477109","allele":{"id":"https://genegraph.clinicalgenome.org/r/19411159-647d-469d-9c07-358d7e334c1d"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/ba806164-f496-4d51-8f90-c3f402135835"}},{"id":"https://genegraph.clinicalgenome.org/r/612eb4ca-a448-4e3f-8ddc-f89d05048598_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18252230","rdfs:label":"Family B","family":{"id":"https://genegraph.clinicalgenome.org/r/612eb4ca-a448-4e3f-8ddc-f89d05048598","type":"Family","rdfs:label":"Family B","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/7d792e99-13ec-4859-97e9-0fa753da5148","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18252230","rdfs:label":"Savage Proband B","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/68e1c46e-f566-432a-8733-31e710a09db7"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0001915","obo:HP_0009926","obo:HP_0002745","obo:HP_0000252","obo:HP_0000953","obo:HP_0000750","obo:HP_0008661","obo:HP_0008404","obo:HP_0001511"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/06959597-fa16-44ff-a21d-b9657873e76c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18252230","allele":{"id":"https://genegraph.clinicalgenome.org/r/68e1c46e-f566-432a-8733-31e710a09db7"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/7d792e99-13ec-4859-97e9-0fa753da5148"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ce1d9803-aded-4ed5-ae6f-7b0b33b88b6c","type":"EvidenceLine","dc:description":"This variant is absent from gnomAD. ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ce1d9803-aded-4ed5-ae6f-7b0b33b88b6c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21199492","allele":{"id":"https://genegraph.clinicalgenome.org/r/19411159-647d-469d-9c07-358d7e334c1d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/5ec98da1-162e-4c2e-bd14-977116989334","type":"EvidenceLine","dc:description":"This variant is absent from gnomAD","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5ec98da1-162e-4c2e-bd14-977116989334_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/d9478926-ff9d-4b42-aed0-abfae5dc469d","type":"EvidenceLine","dc:description":"This variant is absent from gnomAD","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d9478926-ff9d-4b42-aed0-abfae5dc469d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36073719","allele":{"id":"https://genegraph.clinicalgenome.org/r/6d0d5468-6c2a-4ed3-8935-6a1330f78a16","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001099274.3(TINF2):c.844C>T (p.Arg282Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA117653"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/06959597-fa16-44ff-a21d-b9657873e76c","type":"EvidenceLine","dc:description":"This variant is absent from gnomAD","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/06959597-fa16-44ff-a21d-b9657873e76c_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/77e64cc1-9323-4b8e-8816-0e6f02d3a915","type":"EvidenceLine","dc:description":"This variant is absent from gnomAD. ","calculatedScore":2.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/77e64cc1-9323-4b8e-8816-0e6f02d3a915_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The TINF2 c.838A>T (p.K280X) mutation causes a truncated TIN2 protein that leads to telomere dysfunction and cellular senescence, contributing to the phenotype observed in Hoyeraal-Hreidarsson syndrome. This alteration exemplifies a disruption in telomere protection mechanisms critical for genome stability.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/77e64cc1-9323-4b8e-8816-0e6f02d3a915_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22078571","allele":{"id":"https://genegraph.clinicalgenome.org/r/4b89db4d-db20-4b7f-8234-325defcfc35b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001099274.3(TINF2):c.838A>T (p.Lys280Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA343174"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/f3087fb0-6250-4d47-bb27-ae603e2cbcba","type":"EvidenceLine","dc:description":"This variant is absent from gnomAD.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f3087fb0-6250-4d47-bb27-ae603e2cbcba_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18669893","allele":{"id":"https://genegraph.clinicalgenome.org/r/68e1c46e-f566-432a-8733-31e710a09db7"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2843ee25-73d2-47e4-861b-cc4a00efd0ce","type":"EvidenceLine","dc:description":"Variant is absent from gnomAD","calculatedScore":2.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2843ee25-73d2-47e4-861b-cc4a00efd0ce_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Dramatic telomere shortening in one generation is tied to the specific TINF2 c.805C>T (p.Q269X) heterozygous mutation, observed in the proband compared to unaffected family members resulting in he mutation has functional and phenotypic consequences in the patient.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/2843ee25-73d2-47e4-861b-cc4a00efd0ce_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/6ac99ef6-a99d-40e5-b2ec-7a3b049621af","type":"EvidenceLine","dc:description":"Variant is absent from gnomAD","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6ac99ef6-a99d-40e5-b2ec-7a3b049621af_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/b32866f2-6fa1-4a63-9624-3588d0811ea7_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b32866f2-6fa1-4a63-9624-3588d0811ea7_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b87fe11-89b6-4a2a-b976-08db201041d2","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8969405d-a353-45d3-adf6-69d44e0c3cec","type":"Finding","dc:description":"The TIN2-DC mouse model successfully mirrors many key clinical features of human DC, particularly in telomere maintenance, hematopoietic dysfunction, and reproductive decline.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24449270","rdfs:label":"A targeted knock-in allele was engineered with the K267E","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a7ef0a41-f2d6-45ae-bdcf-028b5a1831b3","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f3bf4aee-3cd0-486d-9175-a4754a34cc59","type":"Finding","dc:description":"In humans, DC is characterized by markedly shortened telomeres, which eventually lead to bone marrow failure due to impaired stem cell function. Similarly, in the engineered hESCs, the introduction of the T284R mutation resulted in significant telomere shortening. Moreover, while the hESCs themselves remained viable, their differentiated progeny exhibited a reduced proliferative capacity—a key clinical feature of DC that underlies the bone marrow failure seen in patients.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35421215","rdfs:label":"TINF2‑DC (T284R) mutation into human embryonic stem cells","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityCellCultureModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/b32866f2-6fa1-4a63-9624-3588d0811ea7_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2413deff-e348-48fc-999d-22a25eba6243","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e4628e5-fce4-4281-9b5b-276f06beab0a","type":"FunctionalAlteration","dc:description":"The TIN2-R282H mutation selectively impairs the recruitment of telomerase to telomeres. This altered function leads to a decreased frequency of telomere extension events, resulting in progressive telomere shortening","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26230315","rdfs:label":"Knock‐in of TIN2-R282H in human cells"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/14bd2a94-3b23-45ae-85ee-3d21244e156e","type":"EvidenceLine","dc:description":"The study demonstrated several phenotypes associated with TIN2 mutations and their impact on telomere biology. These phenotypes primarily relate to telomere maintenance and reflect the cellular dysfunctions observed in telomere biology disorders like DC such as; accelerated telomere shortening, Cells expressing TIN2 mutants did not show evidence of telomere capping defects. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c5ed28c8-d302-4c9d-b720-d30e969432b2","type":"FunctionalAlteration","dc:description":"Mutations in TINF2 result in increased telomere attrition, which is consistent with clinical features of diseases like DC. The accelerated shortening likely arises from impaired regulation of telomerase activity or telomere capping.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21536674","rdfs:label":"TIN2 Protein Defective in Association with Telomerase"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/b32866f2-6fa1-4a63-9624-3588d0811ea7_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/54c16a90-4301-44fe-98f1-e8afd20ed2b8","type":"EvidenceLine","dc:description":"This discovery directly ties the PTOP–POT1 interaction to broader protein networks involved in telomere biology and involves coimmunoprecipitation.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8b860954-cd48-4a8e-8c9a-1099ff60afda","type":"Finding","dc:description":"These interactions are shown to regulate telomere maintenance, a critical process in cancer and aging. The study connects protein interactions (e.g., PTOP binding to POT1 and TIN2) with specific functional outcomes like POT1 recruitment to telomeres and telomere length regulation.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15181449","rdfs:label":"TINF2 and telomeric proteins","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5.5}],"evidenceStrength":"Definitive","sequence":10001,"specifiedBy":"GeneValidityCriteria11","strengthScore":17.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/5A8e3wog-tc","type":"GeneValidityProposition","disease":"obo:MONDO_0013522","gene":"hgnc:11824","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_b32866f2-6fa1-4a63-9624-3588d0811ea7-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}